Zepbound and Mounjaro posted triple-digit revenue growth, making Lilly the first health industry giant to reach a ...

In its third-quarter filing, Lilly said its share of the GLP-1 drug market hit 58% in the third quarter. But that's not all.

Bloomberg Economics analysis shows real investment commitments closer to $7 trillion and many of those are in question.

Captive or behind-the-meter supply is projected to meet about 10% of new global demand, with merchant power expected to reach a quarter of global consumption by 2030, double its 2024 share. Morgan ...

Healthcare giant Eli Lilly is now the first global healthcare company to hit $1 trillion in value riding on the popularity of ...